Drug intelligence / Profile preview

D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide

Development stage
Unknown
Lead developer
Derm-Biome Pharmaceuticals
Modality
Small Molecules
01

Overview

D‑phenylalanyl‑N‑{4‑[amino(iminio)methyl]benzyl}‑L‑prolinamide is a synthetic dipeptide small molecule with the chemical formula C22H28N5O2 and a molecular weight of approximately 394.5 g/mol. It is classified as an experimental compound and has not been approved for clinical use in any jurisdiction. There are no known indications, associated conditions, or completed clinical trials for this molecule. Its mechanism of action, pharmacological activity, and therapeutic potential have not been described in publicly available sources[3][4][2].

Other names
D-phenylalanyl-N-(4-(amino(iminio)methyl)benzyl)-L-prolinamideD-Phenylalanyl-N-{4-[amino(Iminio)methyl]benzyl}-L-Prolinamide(amino(4-((((2S)-1-((2R)-2-amino-3-phenylpropanoyl)pyrrolidin-2-yl)formamido)methyl)phenyl)methylidene)azanium{amino[4-({[(2S)-1-[(2R)-2-amino-3-phenylpropanoyl]pyrrolidin–2–yl]formamido}methyl)phenyl]methylidene}azanium

Beyond the preview

Go deeper on D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call